HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

HeartBeam has appointed Bryan Humbarger as Chief Commercial Officer to lead commercial strategy and execution across key growth initiatives, including the limited launch of the HeartBeam System for arrhythmia assessment and heart attack detection. Humbarger will also expand outreach to cardiology partners to validate real-world performance and establish reference sites for broader adoption. The appointment is effective January 22, 2026.